CAMBRIDGE, Mass., Nov. 4, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has moved the date of its third quarter 2016 financial results conference call and webcast from Monday, November 7, 2016, at 4:30 p.m. ET to Wednesday, November 9, 2016, at 4:30 p.m. ET. The change in date is reflect subsequent events that occurred after the end of the quarter, including the license of duvelisib to Verastem, Inc. During the call on Wednesday, November 9, 2016, management will review the company’s third quarter 2016 financial results and provide an update on Infinity’s business.
A live webcast of the conference call can be accessed in the Investors/Media section of Infinity’s website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 1138542. An archived version of the webcast will be available on Infinity’s website for 30 days.
Contact:
Jaren Madden
Senior Director, Investor Relations and Corporate Communications
617-453-1336 or Jaren.Madden@infi.com
Logo - http://photos.prnewswire.com/prnh/20150916/267365LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-moves-the-date-of-its-third-quarter-2016-financial-results-conference-call-and-webcast-300357507.html
SOURCE Infinity Pharmaceuticals, Inc.
